Cubist Systematic Strategies, LLC - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 62 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$50,035
-75.9%
8,778
-78.0%
0.00%
-100.0%
Q2 2022$208,000
-85.6%
39,938
-65.7%
0.00%
-92.9%
Q4 2021$1,448,000
+112.9%
116,303
+434.6%
0.01%
+55.6%
Q3 2021$680,000
+38.2%
21,755
+26.5%
0.01%
+50.0%
Q2 2021$492,000
+77.6%
17,197
+168.9%
0.01%
+50.0%
Q1 2021$277,000
+9133.3%
6,395
+6295.0%
0.00%
Q3 2020$3,0001000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$287,436,0002.91%
Baker Brothers Advisors 10,123,824$289,845,0001.27%
Logos Global Management LP 400,000$11,452,0000.96%
Rock Springs Capital Management LP 382,359$10,947,0000.22%
HHLR ADVISORS, LTD. 583,333$16,701,0000.17%
Virtus ETF Advisers LLC 6,622$190,0000.08%
Jump Financial, LLC 13,700$392,0000.04%
ARS Investment Partners, LLC 7,400$212,0000.02%
FEDERATED HERMES, INC. 336,100$9,623,0000.02%
UBS ASSET MANAGEMENT AMERICAS LLC 1,287,735$36,867,853,0000.02%
View complete list of PRELUDE THERAPEUTICS INC shareholders